有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | 2-(4-tert-butyl-1-methyl-6-oxopyrimidin-2-yl)sulfanyl-N,N-di(propan-2-yl)acetamide | —— | C17H29N3O2S |
|
—— | 2-phenylsulfanyl-N-[(S)-phenyl(1,3-thiazol-2-yl)methyl]acetamide | —— | C18H16N2OS2 |
|
—— | 2-phenylsulfanyl-N-[(R)-phenyl(1,3-thiazol-2-yl)methyl]acetamide | —— | C18H16N2OS2 |
|
—— | (2R)-2-(2,5-dimethylphenyl)sulfanyl-N,N-dimethylpropanamide | —— | C13H19NOS |
|
—— | N-[(1R)-1-(4-ethylsulfanylphenyl)ethyl]-1-methylpyrazole-4-sulfonamide | —— | C14H19N3O2S2 |
|
—— | (2S)-N-benzyl-N-(2,2-dimethylpropyl)-2-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]propanamide | —— | C18H26N4OS |
|
—— | (2S)-2-(2-chlorophenyl)sulfanyl-N-[(3R)-1-methyl-5-oxopyrrolidin-3-yl]propanamide | —— | C14H17ClN2O2S |
|
—— | (2R,6R)-4-[2-(4-chlorophenyl)sulfanylethyl]-2,6-dimethylmorpholin-4-ium | —— | C14H21ClNOS+ |
|
—— | (2R)-2-(2-chlorophenyl)sulfanyl-N-[(3S)-1-methyl-5-oxopyrrolidin-3-yl]propanamide | —— | C14H17ClN2O2S |
|
—— | (2R)-2-(2-chlorophenyl)sulfanyl-N-[(3R)-1-methyl-5-oxopyrrolidin-3-yl]propanamide | —— | C14H17ClN2O2S |
|
—— | N-[(1S)-1-(4-ethylsulfanylphenyl)ethyl]-1-methylpyrazole-4-sulfonamide | —— | C14H19N3O2S2 |
|
—— | (2S)-2-(2-chlorophenyl)sulfanyl-N-[(3S)-1-methyl-5-oxopyrrolidin-3-yl]propanamide | —— | C14H17ClN2O2S |
|
—— | N-[(1S)-1-(2-chlorophenyl)ethyl]-2-[[5-(3,4-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C20H20ClN3O2S |
|
—— | 2-[(3-Bromophenyl)methylsulfanyl]-5-(3,4-dimethylphenyl)-1,3,4-oxadiazole | —— | C17H15BrN2OS |
|
—— | 2-[(2-Bromophenyl)methylsulfanyl]-5-(3,4-dimethylphenyl)-1,3,4-oxadiazole | —— | C17H15BrN2OS |
|
—— | N-[(1R)-1-(4-chlorophenyl)ethyl]-2-[[5-(3,4-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C20H20ClN3O2S |
|
—— | 2-[[5-(3,4-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-[(2R)-4-phenylbutan-2-yl]acetamide | —— | C22H25N3O2S |
|
—— | N-[(1R)-1-(2-chlorophenyl)ethyl]-2-[[5-(3,4-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C20H20ClN3O2S |
|
—— | (2S)-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-methyl-2-phenylsulfanylbutanamide | —— | C19H24N2O2S |
|
—— | 2-[[5-(3,4-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-[(2S)-4-phenylbutan-2-yl]acetamide | —— | C22H25N3O2S |
|
—— | (2S)-2-[[5-(3,4-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]cyclohexan-1-one | —— | C16H18N2O2S |
|
—— | (2S)-2-[[5-(3,4-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-[(2R)-4-phenylbutan-2-yl]propanamide | —— | C23H27N3O2S |
|
—— | (2R)-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-methyl-2-phenylsulfanylbutanamide | —— | C19H24N2O2S |
|
—— | N-[(2R)-2-(dimethylamino)-2-phenylethyl]-2-[[5-(3,4-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C22H26N4O2S |
|
—— | [(1S)-2-[[2-[[5-(3,4-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetyl]amino]-1-phenylethyl]-dimethylazanium | —— | C22H27N4O2S+ |
|
—— | 3-(4-chlorophenyl)sulfanyl-N-[(2S)-2-(dimethylamino)-2-phenylethyl]propanamide | —— | C19H23ClN2OS |
|
—— | (2R)-2-[[5-(3,4-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-[(2R)-4-phenylbutan-2-yl]propanamide | —— | C23H27N3O2S |
|
—— | N-[(1S)-1-cyano-1-cyclopropylethyl]-2-[[5-(3,4-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C18H20N4O2S |
|
—— | (2R)-2-[[5-(3,4-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]cyclohexan-1-one | —— | C16H18N2O2S |
|
—— | 3-[[5-(3,4-Dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanenitrile | —— | C13H13N3OS |
|
—— | ethyl (2S)-2-[[5-(3,4-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-2-phenylacetate | —— | C20H20N2O3S |
|
—— | 2-(3,4-Dimethylphenyl)-5-[(2,5-dimethylphenyl)methylsulfanyl]-1,3,4-oxadiazole | —— | C19H20N2OS |
|
—— | N-[(1R)-1-cyano-1-cyclopropylethyl]-2-[[5-(3,4-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C18H20N4O2S |
|
—— | 3-(4-chlorophenyl)sulfanyl-N-[(2R)-2-(dimethylamino)-2-phenylethyl]propanamide | —— | C19H23ClN2OS |
|
—— | (2R)-N-[2-(cyclohexen-1-yl)ethyl]-2-[[5-(3,4-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanamide | —— | C21H27N3O2S |
|
—— | 3,6-Dimethyl-5-[(2-methylphenyl)methyl]-2-[(4-methylphenyl)methylsulfanyl]pyrimidin-4-one | —— | C22H24N2OS |
|
—— | 2-(3,4-Dimethylphenyl)-5-[(2-thiophen-2-yl-1,3-oxazol-4-yl)methylsulfanyl]-1,3,4-oxadiazole | —— | C18H15N3O2S2 |
|
—— | [(1R)-2-[[2-[[5-(3,4-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetyl]amino]-1-phenylethyl]-dimethylazanium | —— | C22H27N4O2S+ |
|
—— | 5-[(4-Fluorophenyl)methyl]-3,6-dimethyl-2-[(2-methylphenyl)methylsulfanyl]pyrimidin-4-one | —— | C21H21FN2OS |
|
—— | 2-[[5-(3,4-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-[2-(2,4-dioxo-1,3-thiazolidin-3-yl)ethyl]acetamide | —— | C17H18N4O4S2 |
|
—— | (2S)-N-[2-(cyclohexen-1-yl)ethyl]-2-[[5-(3,4-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanamide | —— | C21H27N3O2S |
|
—— | N,N-bis(2-cyanoethyl)-2-[[5-(3,4-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C18H19N5O2S |
|
—— | N-[(1R)-1-(1-adamantyl)ethyl]-2-[[5-(3,4-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C24H31N3O2S |
|
—— | 2-[[5-(3,4-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-[(3S)-1,1-dioxothiolan-3-yl]-N-ethylacetamide | —— | C18H23N3O4S2 |
|
—— | (2R)-N-cyclohexyl-2-[[5-(3,4-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-methylpropanamide | —— | C20H27N3O2S |
|
—— | (2R)-N-benzyl-2-[(6-methyl-5-oxo-4H-1,2,4-triazin-3-yl)sulfanyl]propanamide | —— | C14H16N4O2S |
|
—— | (2S)-N-benzyl-2-[(6-methyl-5-oxo-4H-1,2,4-triazin-3-yl)sulfanyl]propanamide | —— | C14H16N4O2S |
|
—— | 4-methoxy-7,7-dimethyl-8,9a-dihydro-6H-pyrimido[4,5-b][1,4]benzothiazin-9-one | —— | C13H15N3O2S |
|
—— | (3R)-N-(2-phenylsulfanylethyl)oxolane-3-carboxamide | —— | C13H17NO2S |
|
—— | (3S)-N-(2-phenylsulfanylethyl)oxolane-3-carboxamide | —— | C13H17NO2S |
|